Moderna, Inc. (MRNA) Earnings Yield: 5.72%
Is Moderna, Inc.’s earnings yield high or low?
Moderna, Inc.'s earnings yield of 5.72% is 36% below its 5-year average of 8.95%, near the low end of its 5-year range (0.30%–29.07%).
The earnings yield for Moderna, Inc. (MRNA) is 5.72% as of Tuesday, June 9, 2026. It is below its 12-month average by 30.27% (8.20%).
MRNA Earnings Yield Chart
MRNA Average Earnings Yield Chart
MRNA Current vs Average Earnings Yield Chart
MRNA Earnings Yield Metrics
EARNINGS YIELD
5.72%
EARNINGS YIELD AVG TTM
8.20%
EARNINGS YIELD AVG 3Y
6.08%
EARNINGS YIELD AVG 5Y
8.95%
EARNINGS YIELD AVG 10Y
8.80%
EARNINGS YIELD AVG 15Y
8.80%
EARNINGS YIELD AVG 20Y
8.80%
CURRENT VS TTM AVG
-30.27%
CURRENT VS 3Y AVG
-5.90%
CURRENT VS 5Y AVG
-36.07%
CURRENT VS 10Y AVG
-34.99%
CURRENT VS 15Y AVG
-34.99%
CURRENT VS 20Y AVG
-34.99%
MRNA Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | — | 5.72% | 8.20% | 6.08% | 8.95% |
| Hologic, Inc. (HOLX) | $16.97B | 3.16% | 3.63% | 3.48% | 5.61% |
| BioNTech SE (BNTX) | $21.87B | 0.50% | 0.42% | 3.24% | 10.54% |
| Mettler-Toledo International Inc. (MTD) | $23.50B | 3.67% | 3.15% | 3.10% | 2.84% |
| Waters Corporation (WAT) | $24.19B | 2.12% | 3.21% | 3.32% | 3.36% |
| Align Technology, Inc. (ALGN) | $12.76B | 3.35% | 3.51% | 2.66% | 2.47% |
| Veeva Systems Inc. (VEEV) | $27.37B | 3.35% | 2.28% | 1.91% | 1.64% |
| Charles River Laboratories International, Inc. (CRL) | $9.14B | 0.08% | 0.09% | 2.47% | 2.77% |
| Biogen Inc. (BIIB) | $29.39B | 4.69% | 6.31% | 5.95% | 5.80% |
| Bio-Rad Laboratories, Inc. (BIO) | $8.03B | 2.04% | 13.62% | 34.28% | 31.70% |
Earnings Yield vs P/E Ratio
Earnings Yield
5.72%
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
Moderna, Inc. Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Moderna, Inc. Earnings Yield FAQ
- What is the earnings yield for Moderna, Inc. (MRNA)?
- The earnings yield for MRNA stock is 5.72%.
- Is Moderna, Inc.'s earnings yield high or low?
- Moderna, Inc.'s earnings yield of 5.72% is 36% below its 5-year average of 8.95%, near the low end of its 5-year range (0.30%–29.07%).
- What is the TTM average earnings yield for Moderna, Inc. (MRNA)?
- The TTM average earnings yield for MRNA stock is 8.20%.
- What is the 3Y average earnings yield for Moderna, Inc. (MRNA)?
- The 3Y average earnings yield for MRNA stock is 6.08%.
- What is the 5Y average earnings yield for Moderna, Inc. (MRNA)?
- The 5Y average earnings yield for MRNA stock is 8.95%.
- What is the 10Y average earnings yield for Moderna, Inc. (MRNA)?
- The 10Y average earnings yield for MRNA stock is 8.80%.
- What is the 15Y average earnings yield for Moderna, Inc. (MRNA)?
- The 15Y average earnings yield for MRNA stock is 8.80%.
- What is the 20Y average earnings yield for Moderna, Inc. (MRNA)?
- The 20Y average earnings yield for MRNA stock is 8.80%.
Moderna, Inc. Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-09 | 5.72% |
| 2026-06-08 | 5.73% |
| 2026-06-05 | 5.75% |
| 2026-06-04 | 5.29% |
| 2026-06-03 | 5.56% |
| 2026-06-02 | 5.98% |
| 2026-06-01 | 5.93% |
| 2026-05-29 | 5.78% |
| 2026-05-28 | 5.74% |
| 2026-05-27 | 5.73% |
| 2026-05-26 | 5.80% |
| 2026-05-22 | 5.82% |
| 2026-05-21 | 5.78% |
| 2026-05-20 | 5.67% |
| 2026-05-19 | 5.97% |
| 2026-05-18 | 5.68% |
| 2026-05-15 | 5.57% |
| 2026-05-14 | 5.46% |
| 2026-05-13 | 5.41% |
| 2026-05-12 | 5.13% |
| 2026-05-11 | 5.16% |
| 2026-05-08 | 5.02% |
| 2026-05-07 | 5.62% |
| 2026-05-06 | 5.60% |
| 2026-05-05 | 5.84% |
| 2026-05-04 | 5.77% |
| 2026-05-01 | 6.02% |
| 2026-04-30 | 5.94% |
| 2026-04-29 | 5.97% |
| 2026-04-28 | 5.79% |
| 2026-04-27 | 5.61% |
| 2026-04-24 | 5.38% |
| 2026-04-23 | 5.17% |
| 2026-04-22 | 4.91% |
| 2026-04-21 | 5.04% |
| 2026-04-20 | 5.00% |
| 2026-04-17 | 5.08% |
| 2026-04-16 | 4.99% |
| 2026-04-15 | 5.03% |
| 2026-04-14 | 5.17% |
| 2026-04-13 | 5.39% |
| 2026-04-10 | 5.36% |
| 2026-04-09 | 5.32% |
| 2026-04-08 | 5.24% |
| 2026-04-07 | 5.45% |
| 2026-04-06 | 5.60% |
| 2026-04-02 | 5.55% |
| 2026-04-01 | 5.46% |
| 2026-03-31 | 5.37% |
| 2026-03-30 | 5.66% |
| 2026-03-27 | 5.51% |
| 2026-03-26 | 5.10% |
| 2026-03-25 | 5.10% |
| 2026-03-24 | 5.32% |
| 2026-03-23 | 5.32% |
| 2026-03-20 | 5.31% |
| 2026-03-19 | 5.21% |
| 2026-03-18 | 5.21% |
| 2026-03-17 | 5.06% |
| 2026-03-16 | 5.12% |
| 2026-03-13 | 5.19% |
| 2026-03-12 | 5.11% |
| 2026-03-11 | 4.88% |
| 2026-03-10 | 4.97% |
| 2026-03-09 | 4.90% |
| 2026-03-06 | 5.20% |
| 2026-03-05 | 5.07% |
| 2026-03-04 | 4.72% |
| 2026-03-03 | 5.48% |
| 2026-03-02 | 5.17% |
| 2026-02-27 | 5.10% |
| 2026-02-26 | 5.28% |
| 2026-02-25 | 5.31% |
| 2026-02-24 | 5.40% |
| 2026-02-23 | 5.43% |
| 2026-02-20 | 5.47% |
| 2026-02-19 | 5.49% |
| 2026-02-18 | 5.86% |
| 2026-02-17 | 6.22% |
| 2026-02-13 | 6.46% |
| 2026-02-12 | 6.81% |
| 2026-02-11 | 6.74% |
| 2026-02-10 | 6.50% |
| 2026-02-09 | 6.51% |
| 2026-02-06 | 6.66% |
| 2026-02-05 | 6.68% |
| 2026-02-04 | 6.38% |
| 2026-02-03 | 6.47% |
| 2026-02-02 | 6.41% |
| 2026-01-30 | 6.20% |
| 2026-01-29 | 5.83% |
| 2026-01-28 | 6.03% |
| 2026-01-27 | 6.01% |
| 2026-01-26 | 5.69% |
| 2026-01-23 | 5.61% |
| 2026-01-22 | 5.26% |
| 2026-01-21 | 5.48% |
| 2026-01-20 | 6.35% |
| 2026-01-16 | 6.53% |
| 2026-01-15 | 6.93% |
| 2026-01-14 | 6.73% |
| 2026-01-13 | 6.89% |
| 2026-01-12 | 8.06% |
| 2026-01-09 | 7.96% |
| 2026-01-08 | 8.06% |
| 2026-01-07 | 7.60% |
| 2026-01-06 | 7.66% |
| 2026-01-05 | 8.49% |
| 2026-01-02 | 8.85% |
| 2025-12-31 | 9.26% |
| 2025-12-30 | 8.98% |
| 2025-12-29 | 8.76% |
| 2025-12-26 | 8.75% |
| 2025-12-24 | 8.33% |
| 2025-12-23 | 8.45% |
| 2025-12-22 | 7.82% |
| 2025-12-19 | 8.08% |
| 2025-12-18 | 8.82% |
| 2025-12-17 | 8.94% |
| 2025-12-16 | 9.13% |
| 2025-12-15 | 9.12% |
| 2025-12-12 | 9.27% |
| 2025-12-11 | 9.22% |
| 2025-12-10 | 9.41% |
| 2025-12-09 | 9.67% |
| 2025-12-08 | 9.76% |
| 2025-12-05 | 9.85% |
| 2025-12-04 | 10.71% |
| 2025-12-03 | 10.85% |
| 2025-12-02 | 11.35% |
| 2025-12-01 | 11.30% |
| 2025-11-28 | 10.50% |
| 2025-11-26 | 10.92% |
| 2025-11-25 | 11.03% |
| 2025-11-24 | 11.30% |
| 2025-11-21 | 11.51% |
| 2025-11-20 | 12.21% |
| 2025-11-19 | 11.29% |
| 2025-11-18 | 10.95% |
| 2025-11-17 | 11.03% |
| 2025-11-14 | 11.03% |
| 2025-11-13 | 10.94% |
| 2025-11-12 | 10.22% |
| 2025-11-11 | 10.34% |
| 2025-11-10 | 11.03% |
| 2025-11-07 | 11.12% |
| 2025-11-06 | 11.22% |
| 2025-11-05 | 11.59% |
| 2025-11-04 | 11.49% |
| 2025-11-03 | 10.96% |
| 2025-10-31 | 10.05% |
| 2025-10-30 | 9.70% |
| 2025-10-29 | 11.05% |
| 2025-10-28 | 10.76% |
| 2025-10-27 | 10.24% |
| 2025-10-24 | 10.21% |
| 2025-10-23 | 10.40% |
| 2025-10-22 | 10.16% |
| 2025-10-21 | 9.93% |
| 2025-10-20 | 10.02% |
| 2025-10-17 | 10.49% |
| 2025-10-16 | 10.06% |
| 2025-10-15 | 9.85% |
| 2025-10-14 | 10.40% |
| 2025-10-13 | 10.21% |
| 2025-10-10 | 10.17% |
| 2025-10-09 | 9.92% |
| 2025-10-08 | 9.78% |
| 2025-10-07 | 9.99% |
| 2025-10-06 | 9.91% |
| 2025-10-03 | 9.58% |
| 2025-10-02 | 9.62% |
| 2025-10-01 | 9.89% |
| 2025-09-30 | 10.57% |
| 2025-09-29 | 10.78% |
| 2025-09-26 | 11.15% |
| 2025-09-25 | 11.10% |
| 2025-09-24 | 10.55% |
| 2025-09-23 | 10.58% |
| 2025-09-22 | 10.28% |
| 2025-09-19 | 10.81% |
| 2025-09-18 | 10.73% |
| 2025-09-17 | 10.92% |
| 2025-09-16 | 10.99% |
| 2025-09-15 | 11.43% |
| 2025-09-12 | 11.61% |
| 2025-09-11 | 10.75% |
| 2025-09-10 | 11.24% |
| 2025-09-09 | 11.16% |
| 2025-09-08 | 10.99% |
| 2025-09-05 | 10.86% |
| 2025-09-04 | 11.25% |
| 2025-09-03 | 11.35% |
| 2025-09-02 | 11.29% |
| 2025-08-29 | 11.34% |
| 2025-08-28 | 11.16% |
| 2025-08-27 | 10.88% |
| 2025-08-26 | 11.04% |
| 2025-08-25 | 10.76% |
| 2025-08-22 | 10.07% |
| 2025-08-21 | 10.42% |
| 2025-08-20 | 10.15% |
| 2025-08-19 | 9.78% |
| 2025-08-18 | 9.72% |
| 2025-08-15 | 9.75% |
| 2025-08-14 | 10.22% |
| 2025-08-13 | 10.15% |
| 2025-08-12 | 10.64% |
| 2025-08-11 | 10.72% |
| 2025-08-08 | 10.45% |
| 2025-08-07 | 10.26% |
| 2025-08-06 | 10.22% |
| 2025-08-05 | 9.94% |
| 2025-08-04 | 9.88% |
| 2025-08-01 | 9.89% |
| 2025-07-31 | 9.23% |
| 2025-07-30 | 8.49% |
| 2025-07-29 | 8.36% |
| 2025-07-28 | 8.05% |
| 2025-07-25 | 7.99% |
| 2025-07-24 | 8.03% |
| 2025-07-23 | 7.87% |
| 2025-07-22 | 8.34% |
| 2025-07-21 | 8.82% |
| 2025-07-18 | 8.73% |
| 2025-07-17 | 8.48% |
| 2025-07-16 | 8.52% |
| 2025-07-15 | 8.64% |
| 2025-07-14 | 8.31% |
| 2025-07-11 | 8.12% |
| 2025-07-10 | 7.96% |
| 2025-07-09 | 8.33% |
| 2025-07-08 | 8.39% |
| 2025-07-07 | 9.13% |
| 2025-07-03 | 8.95% |
| 2025-07-02 | 9.02% |
| 2025-07-01 | 9.51% |
| 2025-06-30 | 9.89% |
| 2025-06-27 | 10.05% |
| 2025-06-26 | 9.91% |
| 2025-06-25 | 10.16% |
| 2025-06-24 | 10.18% |
| 2025-06-23 | 10.64% |
| 2025-06-20 | 10.54% |
| 2025-06-18 | 10.75% |
| 2025-06-17 | 10.68% |
| 2025-06-16 | 10.50% |
| 2025-06-13 | 10.24% |
| 2025-06-12 | 9.98% |
| 2025-06-11 | 9.84% |
| 2025-06-10 | 9.86% |
| 2025-06-09 | 9.70% |
| 2025-06-06 | 9.94% |
| 2025-06-05 | 10.45% |
| 2025-06-04 | 10.01% |
| 2025-06-03 | 9.81% |
| 2025-06-02 | 10.09% |
| 2025-05-30 | 10.28% |
| 2025-05-29 | 10.14% |
| 2025-05-28 | 10.48% |
Showing the most recent 260 of 1,279 data points. The chart above shows the full history.
Related Metrics
About Moderna, Inc.
Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses like COVID-19, influenza, and respiratory syncytial virus (RSV); latent viral infections such as cytomegalovirus (CMV), Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), herpes simplex virus (HSV), and varicella-zoster virus (VZV); and public health threats like Zika and Nipah. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions. Moderna maintains strategic alliances with several prominent entities, including AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, Carisma Therapeutics, Inc., Metagenomi, Inc., the Defense Advanced Research Projects Agency (DARPA), the Biomedical Advanced Research and Development Authority (BARDA), the Institute for Life Changing Medicines, and The Bill & Melinda Gates Foundation. It also holds a collaboration and license agreement with Chiesi Farmaceutici S.P.A. Founded in 2010 as Moderna Therapeutics, Inc., the company officially became Moderna, Inc. in August 2018. Its corporate headquarters are located in Cambridge, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stéphane Bancel